Current therapeutic strategies for anal squamous cell carcinoma in Japan. 2009

Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo, Japan.

BACKGROUND In Western countries, chemoradiotherapy (CRT) is well established as the standard therapy for stages II/III anal squamous cell carcinoma (ASCC). In Japan, the therapeutic modalities for and outcomes of this disease have not been clarified because ASCC is quite rare. The Colorectal Cancer Study Group of the Japan Clinical Oncology Group (JCOG-CCSG) conducted a survey to determine the current therapeutic strategies for ASCC in Japan. METHODS In July 2006, a questionnaire was sent to 49 institutions affiliated with the JCOG-CCSG to gather information on numbers of cases, therapeutic modalities, and outcomes. The target subjects were patients with stages II/III ASCC, diagnosed from January 2000 to December 2004, who were 20-80 years of age with normal major organ function and no severe complications. RESULTS Replies were received from 40 institutions. A total of 59 patients satisfied the subject criteria. Detailed information was obtained for 55 subjects; 25 (45%) had stage II ASCC and 30 (55%) had stage III ASCC. CRT was performed in 25 patients (45%); surgery in 17 (31%); surgery combined with radiotherapy (RT), chemotherapy, or CRT in 8 (15%); and RT in 5 (9%). Complete response rate in CRT was 80% (20/25). The 3-year progression-free survival rates for all subjects and for CRT-only subjects were 67% and 77%, respectively. CONCLUSIONS From 2000 to 2004, only 59 patients with ASCC were identified in the JCOG-CCSG survey and about half of them underwent CRT.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
December 2023, Liver cancer,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
May 2021, Cancers,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
December 2012, Hematology/oncology clinics of North America,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
August 2016, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
May 2012, Gan to kagaku ryoho. Cancer & chemotherapy,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
December 1953, A.M.A. archives of surgery,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
July 1980, American journal of surgery,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
June 1994, Surgical oncology,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
October 2017, International journal of clinical oncology,
Atsuo Takashima, and Yasuhiro Shimada, and Tetsuya Hamaguchi, and Yoshinori Ito, and Tadahiko Masaki, and Shigeki Yamaguchi, and Yukifumi Kondo, and Norio Saito, and Tomoyuki Kato, and Masayuki Ohue, and Masayuki Higashino, and Yoshihiro Moriya, and
June 2024, International journal of clinical oncology,
Copied contents to your clipboard!